1. Home
  2. PCRX vs SFIX Comparison

PCRX vs SFIX Comparison

Compare PCRX & SFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • SFIX
  • Stock Information
  • Founded
  • PCRX 2006
  • SFIX 2011
  • Country
  • PCRX United States
  • SFIX United States
  • Employees
  • PCRX N/A
  • SFIX N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • SFIX Catalog/Specialty Distribution
  • Sector
  • PCRX Health Care
  • SFIX Consumer Discretionary
  • Exchange
  • PCRX Nasdaq
  • SFIX Nasdaq
  • Market Cap
  • PCRX 1.2B
  • SFIX 482.8M
  • IPO Year
  • PCRX 2011
  • SFIX 2017
  • Fundamental
  • Price
  • PCRX $22.73
  • SFIX $4.19
  • Analyst Decision
  • PCRX Buy
  • SFIX Hold
  • Analyst Count
  • PCRX 8
  • SFIX 4
  • Target Price
  • PCRX $28.38
  • SFIX $5.67
  • AVG Volume (30 Days)
  • PCRX 492.0K
  • SFIX 2.0M
  • Earning Date
  • PCRX 07-29-2025
  • SFIX 06-10-2025
  • Dividend Yield
  • PCRX N/A
  • SFIX N/A
  • EPS Growth
  • PCRX N/A
  • SFIX N/A
  • EPS
  • PCRX N/A
  • SFIX N/A
  • Revenue
  • PCRX $702,772,000.00
  • SFIX $1,275,494,000.00
  • Revenue This Year
  • PCRX $7.92
  • SFIX N/A
  • Revenue Next Year
  • PCRX $11.02
  • SFIX N/A
  • P/E Ratio
  • PCRX N/A
  • SFIX N/A
  • Revenue Growth
  • PCRX 3.08
  • SFIX N/A
  • 52 Week Low
  • PCRX $11.16
  • SFIX $2.21
  • 52 Week High
  • PCRX $27.64
  • SFIX $6.99
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 36.58
  • SFIX 55.62
  • Support Level
  • PCRX $22.23
  • SFIX $3.90
  • Resistance Level
  • PCRX $23.91
  • SFIX $4.56
  • Average True Range (ATR)
  • PCRX 0.82
  • SFIX 0.19
  • MACD
  • PCRX -0.01
  • SFIX 0.05
  • Stochastic Oscillator
  • PCRX 22.03
  • SFIX 64.90

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About SFIX Stitch Fix Inc.

Stitch Fix Inc offers personal style services for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandise with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types, and price points including Women's, Petite, Maternity, Men's, and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags and sells merchandise across various ranges of price points.

Share on Social Networks: